Related Experiment Video
Updated: Jul 3, 2026
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Same-Day Discharge After Transcatheter Aortic Valve Implantation: Who, When, and How?
Hilal Khan1, Debbie Stewart1, Sarah Lamb1
1Cardiothoracic Department, Freeman Hospital, Newcastle Upon Tyne, UK.
Insights
Same-day discharge (SDD) after transcatheter aortic valve implantation (TAVI) is safe and effective for carefully selected low-risk patients. Implementing SDD-TAVI services can improve healthcare efficiency and patient satisfaction.
Area of Science:
- Cardiology
- Interventional Cardiology
- Health Services Research
Background:
- The prevalence of severe aortic stenosis is increasing due to aging populations, leading to higher healthcare demands.
- Transcatheter aortic valve implantation (TAVI) procedures are rising, necessitating efficient healthcare delivery models.
- Previous studies on same-day discharge (SDD) after coronary angioplasty suggest its safety, particularly in transfemoral cases.
Purpose of the Study:
- To provide an overview of the safety and efficacy of same-day discharge (SDD) after transcatheter aortic valve implantation (TAVI).
- To offer guidance on implementing SDD-TAVI services to enhance healthcare efficiency and patient outcomes.
- To highlight the need for randomized trials to validate SDD-TAVI practices.
Main Methods:
- Review of existing observational studies on SDD after TAVI.
- Analysis of technological advancements and procedural evolution in TAVI.
- Discussion of patient selection criteria and minimalist TAVI approaches for SDD.
Main Results:
- Observational studies indicate that SDD after TAVI is safe and effective.
- Careful patient selection and a minimalist TAVI approach are key to successful SDD.
- SDD-TAVI has the potential to improve healthcare system efficiency and patient satisfaction.
Conclusions:
- SDD-TAVI is a viable strategy for selected low-risk patients.
- Successful implementation requires careful patient selection, procedural optimization, and robust follow-up.
- Further randomized trials are needed to confirm the benefits of SDD-TAVI.
Abstract:
The burden of severe aortic stenosis requiring treatment is growing due to ageing populations. This places increased demands on health resources due to the growing number of transcatheter aortic valve implantation (TAVI) procedures and hospital bed occupancy. There are several studies of same-day discharge (SDD) after coronary angioplasty demonstrating its safety, particularly in transfemoral cases. There has been significant evolution in techniques and technologies underpinning TAVI, which have reduced its risk profile over time. As a result, several observational studies have demonstrated that SDD after TAVI is safe and effective. Careful selection of low-risk patients and a minimalist TAVI approach, with appropriate post-procedure review and follow-up, are crucial for successful SDD after TAVI. However, there is a need for randomised trials to validate this practice. This article provides a state-of-the-art overview and guidance to safely and effectively implement a SDD-TAVI service to improve the healthcare system efficiency while enhancing patient satisfaction and recovery.
